What StimLabs’ DermaForm approval reveals about the future of regenerative wound care

StimLabs has secured FDA clearance for DermaForm, expanding its wound care portfolio. Find out what this changes for clinicians and the market.

StimLabs has secured FDA clearance for DermaForm, expanding its wound care portfolio. Find out what this changes for clinicians and the market.

Galderma launches a two-year Sculptra initiative tracking real-world outcomes. Discover what this means for regenerative aesthetics and durability claims.